Lupin shares hit 52-week high on strong Q2 results

[ad_1] Shares of pharmaceutical major Lupin surged as much as 2.18% to hit a 52-week high of ₹1,238.15 apiece on the BSE on Thursday, a day after the company reported…

Cipla plans acquisitions to take top spot in South Africa drug market

[ad_1] Cipla is eyeing the number one position in the South African market, which roughly accounts for a little over 10 per cent of its consolidated turnover. During the first…